Inventor

Dale J. Kempf

Inventor

Libertyville, IL, US

Overview

1989–2019

Patent span

Chemistry

Primary field (CPC C)

Patents· 87 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds25%

A61KPreparations for medical, dental or toiletry purposes21%

C07CAcyclic or carbocyclic compounds17%

C07KPeptides15%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%

Y02PClimate change mitigation technologies in the production or processing of goods1%

C07HSugars1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

C07BGeneral methods of organic chemistry0%

PatentTitleYear

10,238,677Treatment of filarial diseases2019 10,072,040Tylosin A analogs and derivatives2018 9,309,279'Macrocyclic hepatitis C serine protease inhibitors'2016 8,901,157'Compositions and methods of use of ritonavir for treating HCV'2014 8,741,938'Compounds that are useful for improving pharmacokinetics'2014 8,653,141'HIV protease inhibiting compounds'2014 8,642,538'Macrocyclic hepatitis C serine protease inhibitors'2014 8,524,753'Compounds that are useful for improving pharmacokinetics'2013 8,426,388'Prodrugs of HIV protease inhibitors'2013 8,420,596'Macrocyclic hepatitis C serine protease inhibitors'2013 8,338,605'Anti-viral compounds'2012 8,232,246'Anti-viral compounds'2012 8,193,227'HIV protease inhibiting compounds'2012 8,133,892'Compounds that are useful for improving pharmacokinetics'2012 7,968,707'Retroviral protease inhibiting compounds'2011 7,951,800'Anti-infective agents'2011 7,915,411'Anti-viral compounds'2011 7,910,595'Anti-viral compounds'2011 7,902,203'Anti-infective agents'2011 7,834,043'HIV protease inhibiting compounds'2010 7,786,153'Compounds that are useful for improving pharmacokinetics'2010 7,763,731'Anti-viral compounds'2010 7,718,633'Prodrugs of HIV protease inhibitors'2010 7,696,226'HIV protease inhibiting compounds'2010 7,662,958'Anti-infective agents'2010 7,547,678'Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate'2009 7,320,961'Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate'2008 6,831,096'Inhibitors of neuraminidases'2004 6,703,403'Method for improving pharmacokinetics'2004 6,667,404'Retroviral protease inhibiting compounds'2003 6,593,314'Neuraminidase inhibitors'2003 6,531,610'Retroviral protease inhibiting compounds'2003 6,518,305'Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases'2003 6,472,529'Retroviral protease inhibiting compounds'2002 6,455,571'Inhibitors of neuraminidases'2002 6,313,296'Retroviral protease inhibiting compounds'2001 6,284,767'Retroviral protease inhibiting compounds'2001 6,251,906'Retroviral protease inhibiting compounds'2001 6,150,530'Retroviral protease inhibiting compounds'2000 6,037,157'Method for improving pharmacokinetics'2000 6,017,928'Retroviral protease inhibiting compounds'2000 5,990,135'Retroviral protease inhibiting compounds'1999 5,905,068'Retroviral protease inhibiting compounds'1999 5,892,052'Process for making retroviral protease inhibiting compounds'1999 5,886,036'Retroviral protease inhibiting compounds'1999 5,846,987'Retroviral protease inhibiting compounds'1998 5,696,270'Intermediate for making retroviral protease inhibiting compounds'1997 5,679,797'Retroviral protease inhibiting compounds'1997 5,674,882'Retroviral protease inhibiting compounds'1997 5,670,675'Retroviral protease inhibiting compounds'1997 5,659,045'Retroviral protease inhibiting compounds'1997 5,659,044'Retroviral protease inhibiting compounds'1997 5,648,497'Retroviral protease inhibiting compounds'1997 5,635,523'Retroviral protease inhibiting compounds'1997 5,631,376'Retroviral protease inhibiting compounds'1997 5,625,072'Retroviral protease inhibiting compounds'1997 5,621,109'Retroviral protease inhibiting compounds'1997 5,616,720'Retroviral protease inhibiting compounds'1997 5,616,714'Retroviral protease inhibiting compounds'1997 5,608,072'Retroviral protease inhibiting compounds'1997 5,597,927'Retroviral protease inhibiting compounds'1997 5,597,926'Retroviral protease inhibiting compounds'1997 5,597,928'Retroviral protease inhibiting compounds'1997 5,591,860'Retroviral protease inhibiting compounds'1997 5,583,233'Retroviral protease inhibiting compounds'1996 5,583,232'Retroviral protease inhibiting compounds'1996 5,580,984'Retroviral protease inhibiting compounds'1996 5,565,418'Retroviral protease inhibiting compounds'1996 5,554,783'Retroviral protease inhibiting compounds'1996 5,552,558'Retroviral protease inhibiting compounds'1996 5,545,750'Retroviral protease inhibiting compounds'1996 5,541,206'Retroviral protease inhibiting compounds'1996 5,541,334'Retroviral protease inhibiting compounds'1996 5,539,122'Retroviral protease inhibiting compounds'1996 5,461,067'Retroviral protease inhibiting compounds'1995 5,455,351'Retroviral protease inhibiting piperazine compounds'1995 5,354,866'Retroviral protease inhibiting compounds'1994 5,268,374'Non-peptide renin inhibitors'1993 5,256,677'Retroviral protease inhibiting compounds'1993 5,214,129'Peptidylaminodiols'1993 5,151,438'Retroviral protease inhibiting compounds'1992 5,130,468'Process for the preparation of a dipeptide isostere'1992 5,091,575'Peptidylaminodiols'1992 5,032,577'Peptidylaminodiols'1991 4,994,477'Heterocyclic renin inhibitors'1991 4,857,507'Angiotensinogen analogs'1989 4,826,815'Renin inhibiting compounds'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–2013Patents assigned to ABBOTT LAB (75)· patent assignee history

1989–1997Based in Lake Villa, IL, US· patent location history

1992–2018Based in Libertyville, IL, US· patent location history

2010–2014Patents assigned to KEMPF DALE J (11)· patent assignee history

2012–2014Patents assigned to GRAMPOVNIK DAVID J (5)· patent assignee history

2012–2014Patents assigned to CHEN HUI-JU (4)· patent assignee history

2013–2019Patents assigned to ABBVIE INC (9)· patent assignee history

2019Based in North Chicago, IL, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABBOTT LAB	75	1989–2013
KEMPF DALE Jself	11	2010–2014
ABBVIE INC	9	2013–2019
GRAMPOVNIK DAVID J	5	2012–2014
CHEN HUI-JU	4	2012–2014

Locations

Location	Patents	Span
Libertyville, Illinois, US	78	1992–2018
Lake Villa, Illinois, US	8	1989–1997
North Chicago, Illinois, US	1	2019